Literature DB >> 18492748

A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine.

Vijay Panicker1, Christie Cluett, Beverley Shields, Anna Murray, Kirstie S Parnell, John R B Perry, Michael N Weedon, Andrew Singleton, Dena Hernandez, Jonathan Evans, Claire Durant, Luigi Ferrucci, David Melzer, Ponnusamy Saravanan, Theo J Visser, Graziano Ceresini, Andrew T Hattersley, Bijay Vaidya, Colin M Dayan, Timothy M Frayling.   

Abstract

INTRODUCTION: Genetic factors influence circulating thyroid hormone levels, but the common gene variants involved have not been conclusively identified. The genes encoding the iodothyronine deiodinases are good candidates because they alter the balance of thyroid hormones. We aimed to thoroughly examine the role of common variation across the three deiodinase genes in relation to thyroid hormones.
METHODS: We used HapMap data to select single-nucleotide polymorphisms (SNPs) that captured a large proportion of the common genetic variation across the three deiodinase genes. We analyzed these initially in a cohort of 552 people on T(4) replacement. Suggestive findings were taken forward into three additional studies in people not on T(4) (total n = 2513) and metaanalyzed for confirmation.
RESULTS: A SNP in the DIO1 gene, rs2235544, was associated with the free T(3) to free T(4) ratio with genome-wide levels of significance (P = 3.6 x 10(-13)). The C-allele of this SNP was associated with increased deiodinase 1 (D1) function with resulting increase in free T(3)/T(4) ratio and free T(3) and decrease in free T(4) and rT(3). There was no effect on serum TSH levels. None of the SNPs in the genes coding for D2 or D3 had any influence on hormone levels.
CONCLUSIONS: This study provides convincing evidence that common genetic variation in DIO1 alters deiodinase function, resulting in an alteration in the balance of circulating free T(3) to free T(4). This should prove a valuable tool to assess the relative effects of circulating free T(3) vs. free T(4) on a wide range of biological parameters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492748      PMCID: PMC2515080          DOI: 10.1210/jc.2008-0397

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins.

Authors:  Pia Skov Hansen; Thomas Heiberg Brix; Thorkild I A Sørensen; Kirsten Ohm Kyvik; Laszlo Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

Review 2.  New insights into thyroid hormone action.

Authors:  Alexis Oetting; Paul M Yen
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-06       Impact factor: 4.690

3.  Radioimmunoassay of reverse tri-iodothyronine.

Authors:  T J Visser; R Docter; G Hennemann
Journal:  J Endocrinol       Date:  1977-05       Impact factor: 4.286

Review 4.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

Authors:  Antonio C Bianco; Domenico Salvatore; Balázs Gereben; Marla J Berry; P Reed Larsen
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

5.  Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.

Authors:  M J Schneider; S N Fiering; S E Pallud; A F Parlow; D L St Germain; V A Galton
Journal:  Mol Endocrinol       Date:  2001-12

6.  Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations.

Authors:  K A Woeber
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

7.  Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.

Authors:  L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik
Journal:  J Am Geriatr Soc       Date:  2000-12       Impact factor: 5.562

8.  Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis.

Authors:  A Pilo; G Iervasi; F Vitek; M Ferdeghini; F Cazzuola; R Bianchi
Journal:  Am J Physiol       Date:  1990-04

9.  Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects.

Authors:  Robin P Peeters; Hans van Toor; Willem Klootwijk; Yolanda B de Rijke; George G J M Kuiper; Andre G Uitterlinden; Theo J Visser
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China.

Authors:  T-W Guo; F-C Zhang; M-S Yang; X-C Gao; L Bian; S-W Duan; Z-J Zheng; J-J Gao; H Wang; R-L Li; G-Y Feng; D St Clair; L He
Journal:  J Med Genet       Date:  2004-08       Impact factor: 6.318

View more
  43 in total

1.  Genetics of thyroid function and disease.

Authors:  Vijay Panicker
Journal:  Clin Biochem Rev       Date:  2011-11

Review 2.  Novel insights into thyroid hormones from the study of common genetic variation.

Authors:  Colin M Dayan; Vijay Panicker
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

Review 3.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

4.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 5.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

6.  Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.

Authors:  Briseis Aschebrook-Kilfoy; Gila Neta; Alina V Brenner; Amy Hutchinson; Ruth M Pfeiffer; Erich M Sturgis; Li Xu; William Wheeler; Michele M Doody; Stephen J Chanock; Alice J Sigurdson
Journal:  Endocr Relat Cancer       Date:  2012-05-24       Impact factor: 5.678

7.  The relationship of deiodinase 1 genotype and thyroid function to lifetime history of major depression in three independent populations.

Authors:  Robert A Philibert; Steven R H Beach; Tracy D Gunter; Alexandre A Todorov; Gene H Brody; Meeshanthini Vijayendran; Lilly Elliott; Nancy Hollenbeck; Daniel Russell; Carolyn Cutrona
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-05-11       Impact factor: 3.568

Review 8.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

9.  Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment - Data Using a Blind, Randomized, Clinical Study.

Authors:  Allan Carlé; Jens Faber; Rudi Steffensen; Peter Laurberg; Birte Nygaard
Journal:  Eur Thyroid J       Date:  2017-04-24

10.  Variants in MCT10 protein do not affect FT3 levels in athyreotic patients.

Authors:  S Cantara; C Ricci; F Maino; C Marzocchi; F Pacini; M G Castagna
Journal:  Endocrine       Date:  2019-07-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.